Beacon Sciences, LLC, was founded in 2007 based on pioneering work by Dr. Eric V. Anslyn, of The University of Texas, to deliver visible and simple custom assays to the scientific community using the power of chemiluminescence. Our proprietary technology empowers the environmental, life sciences, clinical diagnostics and biodefense industries to retrieve data and results quickly and cost-effectively without the need for heavy and expensive bench-top equipment. Beacon Sciences, LLC, is an Emergent Technologies Inc. (ETI) portfolio company. Headquartered in Austin, Texas, Emergent Technologies, Inc. (ETI) is a life sciences technology investment and management company which provides early stage funding and development for scientific discoveries originating at universities and research institutions. The Company creates value by transforming scientific breakthroughs into technology platforms with multiple applications. ETI’s unique innovation process enables the Company to select promising scientific discoveries for development, maximize the value of intellectual property and manage both cost and risk associated with the commercial development of early stage technologies. ETI is dedicated to turning research into revenue and, in the process, introducing compelling solutions to meet important market needs.